| Jul 18 2024 |
Double Trouble: When D&O Insurance Fails Executives in Dual-Capacity Roles |
Hunton Andrews Kurth |
| Jul 18 2024 |
Because I Got High: Settlement Reached in Terminated Hemp User’s Disability Bias Suit |
Bradley Arant Boult Cummings LLP |
| Jul 18 2024 |
What U.S. Supreme Court Decision on Standing Tells Us About Challenges to Corporate DEI Initiatives |
Jackson Lewis P.C. |
| Jul 17 2024 |
The FTC’s Challenge to the Listing of Device Patents in the Orange Book: What Challenge? |
Polsinelli PC |
| Jul 17 2024 |
2024 Spring Regulatory Agenda Released – Suggests Rulemaking Regarding N-acetyl-L-cysteine |
Keller and Heckman LLP |
| Jul 17 2024 |
Preliminary Injunction Halts Sales of Tumor-Informed Cancer Screening Test |
Bradley Arant Boult Cummings LLP |
| Jul 17 2024 |
The 2025 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know |
ArentFox Schiff LLP |
| Jul 16 2024 |
Supreme Court Decision Overturns Chevron: Impact on Cannabis Industry |
Norris McLaughlin P.A. |
| Jul 16 2024 |
June 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Jul 16 2024 |
Navigating the Legal Boundaries of Telehealth |
Womble Bond Dickinson (US) LLP |
| Jul 16 2024 |
The Science of Drug Testing |
Womble Bond Dickinson (US) LLP |
| Jul 16 2024 |
Defense Contracting, Cybersecurity and COVID: Major Qui Tam Settlements from June 2024 |
Kohn, Kohn & Colapinto |
| Jul 16 2024 |
Second Circuit Remands ‘Whole Wheat Flour’ Cracker Label Lawsuit |
Keller and Heckman LLP |
| Jul 16 2024 |
Patenting Power Plays For AI Drug Discovery |
Foley & Lardner LLP |
| Jul 16 2024 |
Recent Federal Developments, July 2024 |
Bergeson & Campbell, P.C. |
| Jul 15 2024 |
Mintz IRA Update — IRA Litigation Update: Courts Begin to Address Legal Challenges to the Medicare Drug Price Negotiation Program |
Mintz |
| Jul 15 2024 |
Mintz IRA Update — The Consequences and Costs of Redesigning the Part D Program |
Mintz |
| Jul 15 2024 |
Mintz IRA Update — Biden Administration Proposes Allowing Agencies to 'March-In' to Control Rising Drug Prices |
Mintz |
| Jul 15 2024 |
Mintz IRA Update — The Growing Use of State Prescription Drug Affordability Boards |
Mintz |
| Jul 15 2024 |
Mintz IRA Update — Opposition to the Use of March-In Rights to Lower Drug Prices |
Mintz |
| Jul 15 2024 |
Mintz IRA Update — Learning From Experience: Medicare Drug Price Negotiation Program Updates |
Mintz |
| Jul 15 2024 |
USDA’s Biotechnology Regulator Issues Much-Anticipated RFI on Regulation of Modified Microbes |
ArentFox Schiff LLP |
| Jul 12 2024 |
FDA Releases Guidance for Final Rule Regulating Laboratory Developed Tests |
Greenberg Traurig, LLP |
| Jul 12 2024 |
Liquor Code Changes Pass Pennsylvania Legislature |
Norris McLaughlin P.A. |
| Jul 12 2024 |
DOJ Announces Agreement With Rite Aid to Settle Allegations of Violating the FCA and CSA in Relation to Opioid Dispensing |
ArentFox Schiff LLP |
| Jul 12 2024 |
Trending in Telehealth: July 2 – 8, 2024 |
McDermott Will & Schulte LLP |
| Jul 11 2024 |
Loper Bright and the 340B Statute |
McDermott Will & Schulte LLP |
| Jul 11 2024 |
Complying with “Made in USA” Standards, Now a Little Easier and a Little Tougher |
Keller and Heckman LLP |
| Jul 11 2024 |
Is Pleading “Generic” Enough to Plead Inducement? |
McDermott Will & Schulte LLP |
| Jul 10 2024 |
Growing Regulatory Focus on ‘Crossover Alcohol Products’ |
McDermott Will & Schulte LLP |
| Jul 10 2024 |
Five Observations from FDA’s Responses to Comments in the Final Rule on LDTs |
Mintz |
| Jul 10 2024 |
Important Update for New Jersey Alcohol Manufacturers: Changes to Brand Registration and Renewal Process |
Norris McLaughlin P.A. |
| Jul 10 2024 |
Court Vacates TSCA Section 4 Test Order, Grant’s Vinyl Institute’s Petition for Review |
Bergeson & Campbell, P.C. |
| Jul 10 2024 |
USDA’s Spring 2024 Unified Agenda Includes Rulemakings Concerning Biobased Products and Biotechnology |
Bergeson & Campbell, P.C. |
| Jul 10 2024 |
CODEX ALIMENTARIUS: Outcome of 54th Codex Committee on Food Additives (CCFA54) |
Keller and Heckman LLP |
